ChAdOx1 nCoV-19 [ChAdOx1 nCoV-19]
topical
4
- Terms
-
AZD-1222
AZD1222
Covishield
vakcína ChAdOx1 COVID-19
vakcína proti COVID-19, AstraZeneca
vakcína proti COVID-19, Oxford-AstraZeneca
vakcína proti covidu-19, AstraZeneca
vakcína proti covidu-19, Oxford-AstraZeneca
-
AZD-1222
AZD1222
ChAdOx1 COVID-19 Vaccine
COVID-19 Vaccine AstraZeneca
Covishield
Oxford-AstraZeneca COVID Vaccine
Oxford-AstraZeneca COVID-19 Vaccine
Vaxzevria
Persistent link
https://www.medvik.cz/link/D000090985
Definition
A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
- DUI
- D000090985 MeSH Browser
- CUI
- M000747632
- History note
- 2022(2021)
- Public note
- 2022; ChAdOx1 nCoV-19 VACCINE was indexed under COVID-19 VACCINES 2021
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D20.215.894.865.450
Nucleic Acid-Based Vaccines
D20.215.894.899.085.750
BNT162b5